Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

Bibliographic Details
Title: Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
Authors: Lawitz, Eric, Sulkowski, Mark S, Ghalib, Reem, Rodriguez-Torres, Maribel, Younossi, Zobair M, Corregidor, Ana, DeJesus, Edwin, Pearlman, Brian, Rabinovitz, Mordechai, Gitlin, Norman, Lim, Joseph K, Pockros, Paul J, Scott, John D, Fevery, Bart, Lambrecht, Tom, Ouwerkerk-Mahadevan, Sivi, Callewaert, Katleen, Symonds, William T, Picchio, Gaston, Lindsay, Karen L, Beumont, Maria, Jacobson, Ira M
Source: In The Lancet 15-21 November 2014 384(9956):1756-1765
Database: ScienceDirect
More Details
ISSN:01406736
DOI:10.1016/S0140-6736(14)61036-9
Published in:The Lancet
Language:English